Elevated pulmonary vascular resistance predicts mortality in COPD patients
Eur Respir J
.
2021 Aug 26;58(2):2100944.
doi: 10.1183/13993003.00944-2021.
Print 2021 Aug.
Authors
Katarina Zeder
1
2
,
Alexander Avian
3
,
Gerhard Bachmaier
3
,
Philipp Douschan
1
2
,
Vasile Foris
1
2
,
Teresa Sassmann
1
2
,
Natascha Troester
2
,
Luka Brcic
4
,
Michael Fuchsjaeger
5
,
Leigh Matthew Marsh
1
,
Bradley A Maron
6
,
Horst Olschewski
7
2
,
Gabor Kovacs
1
2
Affiliations
1
Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
2
Division of Pulmonology, Dept of Internal Medicine, Medical University of Graz, Graz, Austria.
3
Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.
4
Dept of Pathology, Medical University of Graz, Graz, Austria.
5
Dept of Radiology, Medical University of Graz, Graz, Austria.
6
Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
7
Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria horst.olschewski@medunigraz.at.
PMID:
33986032
DOI:
10.1183/13993003.00944-2021
No abstract available
Publication types
Letter
MeSH terms
Humans
Pulmonary Disease, Chronic Obstructive*
Vascular Resistance